You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2451 to 2475 of about 5948
Next 25
11/25/2012
Trabectedin has promising antineoplastic activity in high-grade meningioma.
11/21/2012
Uninsured brain cancer patients may be more likely than insured to die after surgery to remove tumor
Diffusion Pharmaceuticals Successfully Completes Phase I Brain Cancer Trial
11/20/2012
11/19/2012
Genentech Study Showed That Avastin Helped People with Newly Diagnosed Glioblastoma Live Longer with
11/13/2012
IBTA E NEWS NOVEMBER 2012
Multiple resections for patients with glioblastoma: prolonging survival.
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).
Continuous daily sunitinib for recurrent glioblastoma.
Voices Against Brain Cancer to Host Annual "Join the Voices! Run/Walk" in Partnership with New York Road Runners
Long-term survival of patients suffering from glioblastoma multiforme treated with tumortreating fields.
A phase I/II trial of vandetanib for patients with recurrent malignant glioma.
Health News : Mayo Clinic in Arizona is the First in the Southwest to Offer New Treatment for Recurrent Glioblastoma Brain Tumors
Avastin Reduces Brain Necrosis from Radiation
11/09/2012
Houston’s Dr. Marnie Rose Foundation Exceeds $3 Million in Total Donations to MD Anderson’s Brain Cancer Research, Children’s Memorial Hermann Hospital
11/08/2012
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.
11/07/2012
Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial.
Polifeprosan 20, 3.85% carmustine slow-release wafer (Gliadel) in malignant glioma: evidence for role in era of standard adjuvant temozolomide.
11/01/2012
FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases
10/29/2012
Anti-Alcoholism Drug Helps Fight Deadly Brain Tumor
10/28/2012
Landmark Medicare settlement could change lives
10/22/2012
Los Angeles Goes Grey on November 4, 2012
10/11/2012
IBTA E NEWS OCTOBER 2012
UC Irvine opens clinical trial of novel treatment for brain cancer
10/10/2012
Bevacizumab (Avastin) continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.